Animal Genetics Market Report Scope & Overview

The animal genetics market size was USD 6.44 billion in 2023 and is expected to reach USD 11.47 billion by 2032 and grow at a CAGR of 6.62% over the forecast period of 2024-2032. This report on the animal genetics market provides comprehensive insights into livestock population trends, artificial insemination and embryo transfer adoption rates, and advancements in genomic selection. It analyzes regulatory impacts, funding trends, and key innovations shaping the industry.

Additionally, the report highlights success rates in breed improvement, disease resistance data, and sustainability metrics related to genetic advancements. Export and import trends of genetic materials, along with patent filings, are also covered to assess market dynamics. The study further explores the impact of genetic technologies on productivity and efficiency across various livestock species. With a focus on statistical data, emerging trends, and industry developments, this report offers a deep understanding of the market landscape.

The U.S. held the largest market share in the animal genetics market, reaching a market size of USD 1.85 billion in 2023, accounting for 76% of the global market. This dominance is driven by the country’s advanced biotechnology infrastructure, high adoption of artificial insemination (AI) and embryo transfer techniques, and a well-established livestock industry. The presence of key market players, such as Genus Plc, Zoetis Inc., and Neogen Corporation, further strengthens the industry with continuous investments in research and development. Additionally, the rising demand for high-quality livestock breeds, increasing consumption of animal protein, and government support for genetic research in agriculture contribute to the market's expansion. The U.S. also benefits from strict regulatory standards ensuring genetic quality and traceability, making it a global leader in animal genetics.

Market Dynamics

Drivers

• Rising demand for high-quality livestock breeds and genetic advancements drive the animal genetics market growth.

The growing global population and increasing demand for high-quality animal protein have led to a surge in genetically superior livestock breeds. Advances in artificial insemination (AI), embryo transfer, and genome editing technologies have enabled farmers to enhance livestock productivity, disease resistance, and overall genetic quality. The adoption of genomic selection and marker-assisted breeding has further optimized breeding efficiency, ensuring improved meat, milk, and egg production. Additionally, the rising investments in biotechnology and government support for genetic research have accelerated the adoption of animal genetics solutions. As a result, the market is witnessing a rapid transformation in breeding techniques, making genetic advancements a crucial driver for growth in the industry.

Restrain

• Ethical concerns and regulatory challenges restrain the growth of the animal genetics market.

The animal genetics industry faces significant challenges due to ethical concerns, regulatory barriers, and stringent government policies. The use of genetic modification and genome editing in livestock raises concerns over animal welfare, biodiversity loss, and potential long-term health risks. Regulatory bodies such as the FDA, USDA, and EFSA impose strict guidelines and approval processes, limiting the commercialization of genetically modified animals. Additionally, public resistance toward genetically engineered animals, particularly in Europe and North America, has created hurdles for market expansion. Compliance with biosafety regulations and intellectual property rights also increases the cost and complexity of genetic research. These factors, combined with the lack of standardized policies across different countries, pose a restraint on the widespread adoption of advanced genetic technologies.

Opportunity

• Expansion of precision livestock farming and genetic testing presents new growth opportunities

The integration of precision livestock farming (PLF) technologies with genetic advancements is creating new growth opportunities in the animal genetics market. The adoption of sensor-based monitoring systems, artificial intelligence (AI), and big data analytics is enhancing genetic selection processes, allowing farmers to improve livestock health and productivity. Genetic testing is also gaining traction, enabling early disease detection, parentage verification, and breed optimization. Additionally, the increasing investments in developing low-cost genetic screening tools are making genetic solutions accessible to small and mid-sized farms. Emerging markets, particularly in Asia-Pacific and Latin America, present untapped opportunities as livestock farmers seek high-performance breeds to meet growing protein demand. As technology-driven breeding practices gain momentum, the market is expected to expand significantly in the coming years.

Challenge

• High costs of genetic research and breeding technologies pose a major market challenge.

The high cost associated with genetic research, breeding technologies, and biotechnology innovations remains a major challenge for the animal genetics market. The development of genetically enhanced livestock requires significant investments in R&D, specialized infrastructure, and skilled personnel. The cost of advanced reproductive technologies, such as in-vitro fertilization (IVF), embryo transfer, and genomic selection, makes it difficult for small and medium-sized farmers to adopt these solutions. Additionally, high costs of genetic testing, animal health monitoring, and cryopreservation techniques further restrict market accessibility. Financial constraints, particularly in developing countries, limit the widespread adoption of animal genetics solutions. Without cost-effective genetic improvement programs and financial support mechanisms, market penetration in emerging regions remains a challenge, hindering the overall growth potential of the industry.

Segmentation Analysis

By Type

The animal genetics market was dominated by the ART segment, which held 52.00% of the total revenue in 2023, owing to the increasing adoption of artificial insemination (AI), embryo transfer (ET), and in-vitro fertilization (IVF). Many companies, such as Genus Plc and Zoetis Inc., have been growing their ART portfolios, and more recently, Zoetis has introduced ART-based solutions for genetic selection. The increasing need for high-yielding and disease-resistant livestock has stimulated the uptake of ART to expedite genetic trait enhancements and help in efficient breeding. This reflects the wider growth of the animal genetics market and the burgeoning interest in precision breeding across it.

By Application

Cattle is anticipated to hold 44% of the market share, making it expected to be the leading animal genetics market segment. Investments in cattle genetic improvement programs have been a result of the growing worldwide needs for premium dairy and meat products. Neogen Corporation and URUS, among other companies, have launched sophisticated genomic testing and AI-based solutions for improving cattle reproduction and enhancing disease resistance, respectively. Combining genomic selection with marker-assisted breeding has further reinforced the segment amid the rising need to improve milk yield, optimize meat quality, and improve the overall productivity of livestock for cattle breeders.

By Distribution Channel

The private distribution channel is anticipated to lead with 68% of the market share during the forecast period, owing to the increased involvement of private genetic service providers and breeding companies as well as biotech firms. Private AI has already been opened by companies like Hendrix Genetics and Topigs Norsvin, bringing AI and genetic solutions to livestock farmers everywhere. Private-sector investments have also been driven by increasing interest in developing tailored breeding programs, genetic testing kits, and working directly with farmers. Such an approach is a key trend driving the growth of the global animal genetics market, facilitating the access to genetic selection and breeding technologies to all scale livestock enterprises.

Regional Analysis

North America held the largest market share at around 38% in 2023. It is owing to the adoption of advanced breeding technologies, growth in genetic research and investments in North America, and high demand for high-quality livestock breeds in the region. Key players such as Zoetis Inc. and Neogen Corporation are leveraging the forefront of genomic testing solutions for better animal health and productivity, contributing to the dominance of the region. In 2023, Zoetis rolled out new genetic evaluation tools for cattle breeders worldwide to help them make faster selections to improve their breeding programs. Moreover, the increasing use of artificial insemination (AI) and in-vitro fertilization (IVF) on dairy and beef cattle farms has bolstered market expansion. Existing strong livestock farming sectors in the U.S. and Canada also contribute to increased demand for genetic improvement technologies, strengthening North America as a leader in the animal genetics market internationally.

Europe held a significant market share in 2023. It is due to growth in the implementation of genetic research investments, demand for high-quality livestock, and strong government support for the implementation of sustainable animal breeding in the region. Genomic choice, AI, and embryo transfer progress fast at the modernization pace of countries like Germany, France, and the Netherlands. Hendrix Genetics enhanced its animal programs for poultry and swine in 2023 by expanding its genetic improvement programs for breed efficiency and resilience to diseases. Neogen Corporation also introduced new genomics testing solutions for precision breeding in Europe. Rapid market growth due to the region`s approach towards animal productivity enhancement by complying to strict EU animal welfare and sustainability directives are driving the growth of Europe within the global market scenario.

Key Players

• Genus Plc (PIC Genetics, IntelliGen Technologies)

• Envigo Corporation (Teklad Diets, Envigo Genetic Models)

• Topigs Norsvin (TN70 Sows, Norsvin Landrace)

• CRV Holding B.V. (Better Life Health, CRV Fleckvieh)

• Groupe Grimaud La Corbiere SA (NOVOGEN Layers, Hubbard Broilers)

• Hendrix Genetics BV (Hybrid Layers, Hypor Pigs)

• Neogen Corporation (Igenity Genomic Profiles, GeneSeek Genomic Services)

• Zoetis, Inc. (Clarifide Genomics, Fostera Vaccines)

• URUS (GENEX Genetics, PEAK Genetics)

• Animal Genetics, Inc. (Equine Genetic Testing, Canine DNA Testing)

• ABS Global (Sexcel Sexed Semen, NuEra Genetics)

• STgenetics (UltraPlus Sexed Semen, Chromatin Technology)

• VikingGenetics (VikingJersey, VikingHolstein)

• Noble Genetics (Noble Sires, Swine Genetic Solutions)

• Alta Genetics (Alta Advantage, Alta Bull Search)

• WUR Livestock Research (Precision Breeding, Dairy Genomics)

• Genex Cooperative (Calf Math, Real World Data Genomics)

• Cogent Breeding Ltd. (VisioGen, SexedULTRA Semen)

• Semex (Immunity+ Genetics, Semex ai24)

• Rocky Mountain Genetics (Bovine IVF Solutions, Custom Embryo Transfer)

Recent Development:

• In October 2024, SCHOTT Pharma, in partnership with Schreiner MediPharm and Körber Pharma, launched a blister-free syringe packaging solution to cut plastic waste and lower carbon emissions. This eco-friendly design replaces polymer blisters with 100% cardboard mono-material cartons, enhancing sustainability.

• In October 2023, SCHOTT AG introduced FIOLAX Pro, an advanced Type I borosilicate glass tubing designed for the pharmaceutical industry. This innovation enhances chemical quality, eliminates heavy metals, and supports complex drug formulations.